Xu Xiao Hong . Clinical Analysis of Preoperative Neoadjuvant Chemotherapy by Thalidomide Combined with Gefitinib for Non-small Cell Lung Cancer[J]. Journal of Kunming Medical University, 2016, 37(01).
Citation: Lv Song Qin , Zhao Hua , Bao Fu Kai , Li Xiao Fei , Yan Xin Li , Zhang Juan , Duan Hong Fen . Combined Application of TNF-α,IFN-γ and T-SPOT.TB in Identification between Active Tuberculosis Infection and Latent Tuberculosis Infection[J]. Journal of Kunming Medical University, 2017, 38(04): 93-97.

Combined Application of TNF-α,IFN-γ and T-SPOT.TB in Identification between Active Tuberculosis Infection and Latent Tuberculosis Infection

Funds:

基金: 昆明市科技局区城创新与科技惠民基金资助项目(2014-04-A-S-02-3091);

  • Received Date: 2016-10-19
  • Objective To find cytokine index which can make a identification between active tuberculosis infection and latent tuberculosis infection and provide new evidence for tuberculosis diagnosis,we evaluated the levels of IL-2,IL-4,IL-6,IL-10,TNF-α and IFN-γ in people with active tuberculosis,latent tuberculosis infected people and normal people. Methods We detected the serum levels of six cytokines(IL-2, IL-4,IL-6, IL-10, TNF-α and IFN-γ) of 60 tuberculosis cases with T-SPOT.TB(+), 55 cases with latent tuberculosis infection and T-SPOT.TB(+),30 cases of normal people with T-SPOT.TB(-) by cytometric bead array(CBA). Results Compared with other groups, the levels of IL-2, IL-6, TNF-α and IFN-γ of tuberculosis(sputum culture positive) group were significantly increased(P<0.05). About IL-10,there were significant differences between two groups and the levels of IL-10 increased along with the increasing activity of tubercle bacillus and the severity of tuberculosis. TNF-α and IFN-γ of two tuberculosis groups were significantly higher than latent tuberculosis infected group and normal group(P<0.05).The serum levels of IL-4 showed no significant difference between different groups(P >0.05). Conclusions Combined with T-SPOT.TB, the detection of TNF-α and IFN-γ can make a identification between active tuberculosis infection and latent tuberculosis infection at the cytokine level, which is of great importance for the diagnosis and differentiation of latent tuberculosis infection.
  • [1]
    [1]WORLD HEALTH ORGANIZATION.Golbal tuberculosis report 2015[R/OL].[2015-11-16].World Orangization,2015.http://www.who.int/tb/publications/global_report/en/.
    [2]
    [2]FRIEDEN T R,STERLING T R,MUNSIFF S S,et al.Tuberculosis[J].Lancet,2003,362(9387):887-899.
    [3]
    [3]DIEL R,LODDENKEMPER R,NIENHAUS A.Evidence-Based Comparison of Commercial Interferon-gamma Release Assays for Detecting Active TB[J].Chest,2009,137(4):952-68.
    [4]
    [4]COKER R.Ending Neglect:The elimination of tuberculosis in the united states[J].Jama the Journal of the American Medical Association,2001,286(2):232-233.
    [5]
    [5]JIANG B,DING H,LI Z,et al.Evaluation of interferon-gamma release assay(T-SPOT.TBTM)for diagnosis of tuberculosis infection in rheumatic disease patients[J].International Journal of Rheumatic Diseases,2016,19(1):38-42.
    [6]
    [6]WORLD HEALTH ORGANIZATION.Guidelines on the management of latent tuberculosis infection[R/OL].[2015-11-16].World Health Organization,2015.http://www.who.int/tb/publications/ltbi_document_page.
    [7]马锡慧,肖漓,石炳毅.流式微珠阵列术在医学中的研究进展[J].生物技术通讯,2016,27(1):138-141.
    [8]
    [8]JOHNSON J L,SSEKASANVU E,OKWERA A,et al.Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis[J].American Journal of Respiratory&Critical Care Medicine,2003,168(2):185-191.
    [9]
    [9]BERMUDEZ L E,YOUNG L S.Tumor necrosis factor,alone or in combination with IL-2,but not IFN-gamma,is associated with macrophage killing of Mycobacterium avium complex.[J].Journal of Immunology,1988,140(9):3006-3013.
    [10]
    [10]BERMUDEZ L E,STEVENS P,KOLONOSKI P,et al.Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2and tumor necrosis factor.[J].Journal of Immunology,1989,143(9):2996-3000.
    [11]
    [11]JEEVAN A,ASHERSON G L.Recombinant interleukin-2limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.[J].Infection&Immunity,1988,56(3):660-664.
    [12]
    [12]VERBON A,JUFFERMANS N P,DEVENTER V,et al.Serum concentrations of cytokines in patients with active tuberculosis(TB)and after treatment[J].Clinical&Experimental Immunology,1999,115(1):110-113.
    [13]
    [13]REDFORD P S,MURRAY P J,O'GARRA A.The role of IL-10 in immune regulation during M.tuberculosis infection.[J].Mucosal Immunology,2011,4(3):261-270.
    [14]
    [14]CYKTOR J C,CARRUTHERS B,KOMINSKY R A,et al.IL-10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection.[J].Journal of Immunology,2013,190(6):2778-2790.
    [15]
    [15]FORTSCH D,ROLLINGHOFF M,STENGER S,et al.IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis.[J].Journal of Immunology,2000,165(2):978-987.
    [16]
    [16]HUR YG,GORAK-STOLINSKA P,BEN-SMITH A,et al.Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.[J].Plos One,2013,8(11):e79742-e79742.
    [17]冯经华,尹凤鸣,严振球.目前结核分枝杆菌感染中重要免疫细胞和细胞因子作用的研究进展[J].临床军医杂志,2007,35(2):291-295.
    [18]
    [18] JINFANG Z,PAUL W E.CD4 T cells:Fates,functions,and faults[J].Blood,2008,112(5):1557-1569.
  • Relative Articles

    [1] Haixia GU, Jiangli PENG, anxin CHEN, Rui YIN, qiqi XIAO, Jie CHEN. Clinical Characteristics and Prognostic Analysis of Maintenance Hemodialysis Patients With Initial Treatment Tuberculosis. Journal of Kunming Medical University, 2025, 46(): 1-7.
    [2] Shibing QIAN, Huiping SHI, Yanqiu LI, Rongyu YANG, Kaiwen DUAN. Research Progress on Osteogenic Differentiation of Apical Papilla Stem Cells. Journal of Kunming Medical University, 2024, 45(9): 168-173.  doi: 10.12259/j.issn.2095-610X.S20240926
    [3] Fen LI, Jie ZHAO, Haixi ZHANG, Lin ZHANG, Xuezhong GU. The Correlation of Iron Metabolism Indexes,Cytokines,and Liver Function in Patients with Hemophagocytic Syndrome. Journal of Kunming Medical University, 2024, 45(11): 110-116.  doi: 10.12259/j.issn.2095-610X.S20241115
    [4] Xinye YANG, Nian ZHANG, Sha MA, Linpei HUANG, Xueyi LI, Xiaoping HUANG, Mi ZHANG, Cuixian YANG, Xicheng WANG. Analysis of Laboratory Index Characteristics in Newly Treated Smear-Negative Pulmonary Tuberculosis Patients. Journal of Kunming Medical University, 2024, 45(9): 56-61.  doi: 10.12259/j.issn.2095-610X.S20240909
    [5] Kun ZHAO, Yun XIAO, Chun YANG, Zhiling YAN, Minna DONG, Bingquan XIANG, Mingyao XIAO. Protective Effect of Interleukin-4 in Lipopolysaccharide-induced Acute Lung Injury Models. Journal of Kunming Medical University, 2022, 43(8): 41-46.  doi: 10.12259/j.issn.2095-610X.S20220805
    [6] Chunhong YU, Yanhong ZHAO, Xing LIU, Lingjun SHEN, Weixian LI, Haiwen LI, Hao FAN. Early Effectiveness of Bedaquiline Containing Regimen in Treatment of Multidrug-resistant and Extensively Drug-resistant Pulmonary Tuberculosis: An One-arm Observational Study of 24 Weeks. Journal of Kunming Medical University, 2022, 43(11): 99-106.  doi: 10.12259/j.issn.2095-610X.S20221113
    [7] Xing LIU, Hai-wen LI, Hong-li HUANG, Lin-jun SHEN, Le ZHANG, Xiang-fang LIU, Wen-lin ZHANG, Lu WANG. Effects of Probiotics Enhanced Enteral Nutrition on Gastrointestinal Function and Cytokines in Patients with Severe Acute Pancreatitis. Journal of Kunming Medical University, 2021, 42(11): 81-86.  doi: 10.12259/j.issn.2095-610X.S20211116
    [8] Jin-rong YANG, Kun WU, Bo NIE, Zhen-xin HE, Yu-yu YANG, Jie SUN, Yun ZENG. Clinical Features of Adult HPS and the Correlation between Cytokine Levels and Prognosis. Journal of Kunming Medical University, 2021, 42(12): 51-58.  doi: 10.12259/j.issn.2095-610X.S20211220
    [9] Wei-sha ZHOU, Le ZHANG, Jing PENG, Shou-kun CHEN, Meng-jun LIU, Xiao FU, Zhi-fei TANG, Yun-xuan YUE. Effect of Plasma Exchange with Double Plasma Molecular Adsorption on Cytokines in Autoimmune Hepatitis with Liver Failure. Journal of Kunming Medical University, 2021, 42(4): 73-77.  doi: 10.12259/j.issn.2095-610X.S20210414
    [10] Yan-fen MA, Jian HU, Ning ZHANG, Qian WU, Xiao-qin WANG. Changes and Abnormal Patterns of Coagulation Indicators in Patients with Lung Adenocarcinoma and Tuberculosis Pleural Effusion. Journal of Kunming Medical University, 2021, 42(10): 145-150.  doi: 10.12259/j.issn.2095-610X.S20211021
    [11] Zhe GE, Si-ping LU, Shi-zhong FU, Chun-hong WANG, Shao-ying LI, Ao LIU. The Preliminary Application of Whole Blood Interferon-Gamma Release Assay Combined with T Lymphocyte Subset Detection in Diagnosis of Pulmonary Tuberculosis. Journal of Kunming Medical University, 2021, 42(9): 108-113.  doi: 10.12259/j.issn.2095-610X.S20210901
    [12] Wei-jia ZHAO, Hong-bin LI, Zong-han CHEN. Evaluation of Peripheral Blood Cytokine Levels before and after Psoriasis Treatment with Narrow-spectrum UVB Combined with Carpotriol. Journal of Kunming Medical University, 2020, 41(12): 99-103.  doi: 10.12259/j.issn.2095-610X.S20201227
    [13] Yang Jing . . Journal of Kunming Medical University,
    [14] Xue En Zhong . . Journal of Kunming Medical University,
    [15] Yang Jing . . Journal of Kunming Medical University,
    [16] Yang De Xing . . Journal of Kunming Medical University,
    [17] Shu Jing Kui . . Journal of Kunming Medical University,
    [18] Wan Rong . . Journal of Kunming Medical University,
    [19] . . Journal of Kunming Medical University,
    [20] . Clinical Application of T-SPOT.TB in Diagnosis of HIV/AIDS and TB Patients. Journal of Kunming Medical University,
  • Cited by

    Periodical cited type(21)

    1. 林洪盛,刘利敏,鲁秋香,吴清. 新辅助化疗对非小细胞肺癌患者肿瘤标志物与细胞凋亡相关因子的影响. 中国医学创新. 2023(03): 45-49 .
    2. 何佳,白美玲. 吉非替尼靶向治疗非小细胞肺癌对患者血清CA125、CEA、NSE水平及不良反应的影响. 当代医学. 2021(18): 167-168 .
    3. 何显阳,刘方文,黄云英,赖红宇,王志春. 多西他赛联合顺铂新辅助化疗对非小细胞肺癌治疗中相关肿瘤标记物的影响. 医学信息. 2021(23): 165-167 .
    4. 吴皓,李萍. 奥希替尼联合放化疗治疗晚期非小细胞肺癌患者的临床疗效及安全性分析. 中国肿瘤临床与康复. 2020(04): 400-403 .
    5. 雒润华. 健脾化痰逐淤方结合靶向药物治疗晚期EGFR突变阳性肺腺癌. 深圳中西医结合杂志. 2020(14): 45-46 .
    6. 章伟. 吉非替尼靶向治疗对非小细胞肺癌患者血清CA125 CEA NSE水平的影响. 基层医学论坛. 2020(26): 3846-3847 .
    7. 曹参,李靖,吴勤研. 吉非替尼联合化疗方案应用于晚期肺腺癌患者的临床疗效及安全性分析. 中华肺部疾病杂志(电子版). 2020(04): 484-487 .
    8. 姚丽鸽,王留晏,周寒丽,段方方,陈露,张克克. 沙利度胺联合GP方案化疗对晚期非小细胞肺癌患者生存时间和生存质量的影响. 癌症进展. 2019(12): 1400-1403 .
    9. 张治业. 沙利度胺联合TP方案化疗对晚期非小细胞肺癌患者血清肿瘤标志物的影响. 淮海医药. 2019(04): 338-340 .
    10. 廖丽军,李鹏辉. 新辅助化疗治疗Ⅲ期非小细胞肺癌的临床疗效观察. 中国现代医生. 2019(19): 102-104 .
    11. 文慧,彭彦才,艾葆春,郝光军,李小峰. 阿帕替尼联合紫杉醇对非小细胞肺癌患者的疗效及血清因子的影响. 药物评价研究. 2019(09): 1810-1813 .
    12. 莫遗盛,周伯庭,毛艳,王冬梅. 沙利度胺治疗实体瘤的研究进展. 微创医学. 2018(03): 344-347 .
    13. 惠广盈,刘楠. 手术前后联合化疗对非小细胞肺癌患者生存质量及不良反应的影响. 西北国防医学杂志. 2018(01): 35-38 .
    14. 顾晶晶. 吉非替尼联合沙利度胺治疗非小细胞肺癌的临床疗效分析. 中国现代应用药学. 2018(07): 1073-1076 .
    15. 梁华,李彦磊,高炜. 吉非替尼联合化疗治疗原发性ⅢB、Ⅳ期非小细胞肺癌的临床研究. 中国医学前沿杂志(电子版). 2018(03): 58-61 .
    16. 王宏,夏永寿,加静,张燕,王瑛. 沙利度胺联合吉非替尼靶向治疗非小细胞肺癌的临床效果观察. 现代生物医学进展. 2018(23): 4474-4477 .
    17. 武乐,叶华姝,刘震天. 吉非替尼与沙利度胺联用对非小细胞肺癌患者的临床疗效及其对CEA和CA125水平的影响. 抗感染药学. 2018(12): 2118-2121 .
    18. 杨建刚,陈继正,赵参军,王昕洁,钱仲,郑瑾. 沙利度胺在治疗晚期实体肿瘤中的应用及研究进展. 现代肿瘤医学. 2017(11): 1805-1809 .
    19. 玛依拉·阿不都克力木,库尔班江·吐尔逊. 沙利度胺联合吉非替尼新辅助化疗对非小细胞肺癌患者的疗效与安全性分析. 实用癌症杂志. 2017(04): 582-585 .
    20. 龚玉芳,刘峰,杨志胤,姜斌. 新辅助化疗前后非小细胞肺癌患者血清CA125、CEA及CYFRA21-1的变化及预后分析. 中国医药导报. 2017(11): 91-94 .
    21. 胡洪林. 吉非替尼联合简化调强放疗技术治疗非小细胞肺癌临床研究. 中国药业. 2017(09): 38-40 .

    Other cited types(1)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 26.0 %FULLTEXT: 26.0 %META: 74.0 %META: 74.0 %PDF: 0.1 %PDF: 0.1 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 4.1 %其他: 4.1 %China: 4.5 %China: 4.5 %上海: 6.1 %上海: 6.1 %丽水: 0.0 %丽水: 0.0 %九江: 0.1 %九江: 0.1 %北京: 23.2 %北京: 23.2 %南京: 0.1 %南京: 0.1 %台州: 0.4 %台州: 0.4 %哥伦布: 0.0 %哥伦布: 0.0 %嘉兴: 0.0 %嘉兴: 0.0 %天津: 0.1 %天津: 0.1 %安那罕: 0.1 %安那罕: 0.1 %宣城: 0.0 %宣城: 0.0 %广州: 0.0 %广州: 0.0 %张家口: 0.3 %张家口: 0.3 %成都: 0.0 %成都: 0.0 %扬州: 0.0 %扬州: 0.0 %攀枝花: 0.0 %攀枝花: 0.0 %无锡: 0.1 %无锡: 0.1 %昆明: 0.2 %昆明: 0.2 %杭州: 0.2 %杭州: 0.2 %武威: 0.1 %武威: 0.1 %武汉: 0.1 %武汉: 0.1 %洛杉矶: 0.0 %洛杉矶: 0.0 %淄博: 0.0 %淄博: 0.0 %淮北: 0.1 %淮北: 0.1 %湖州: 0.4 %湖州: 0.4 %漯河: 0.2 %漯河: 0.2 %石家庄: 0.0 %石家庄: 0.0 %绍兴: 0.2 %绍兴: 0.2 %芒廷维尤: 1.3 %芒廷维尤: 1.3 %芝加哥: 0.0 %芝加哥: 0.0 %苏州: 0.1 %苏州: 0.1 %荆州: 0.0 %荆州: 0.0 %衢州: 0.2 %衢州: 0.2 %西宁: 4.0 %西宁: 4.0 %许昌: 0.1 %许昌: 0.1 %郑州: 0.7 %郑州: 0.7 %金华: 0.1 %金华: 0.1 %铁岭: 0.0 %铁岭: 0.0 %锦州: 0.0 %锦州: 0.0 %马赛: 0.0 %马赛: 0.0 %驻马店: 52.7 %驻马店: 52.7 %黄石: 0.0 %黄石: 0.0 %其他China上海丽水九江北京南京台州哥伦布嘉兴天津安那罕宣城广州张家口成都扬州攀枝花无锡昆明杭州武威武汉洛杉矶淄博淮北湖州漯河石家庄绍兴芒廷维尤芝加哥苏州荆州衢州西宁许昌郑州金华铁岭锦州马赛驻马店黄石

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2679) PDF downloads(109) Cited by(22)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return